Transcript text: With respect to BRAF V600E testing:
A. A positive BRAF V600E test by immunohistochemistry can be used to decide therapy with BRAF inhibitors in patients with advanced melanoma
B. There is a significant discrepancy between immunohistochemistry and molecular testing
C. The immunohistochemical test needs to be reported according to a specific scoring system
D. The immunohistochemical test shows low specificity and sensitivity